Skip to contentSkip to Braille Studio

Library / Laws / 119th Congress / House Bills / H.R. 1262

H.R. 1262

To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.

Print stageDateSize⠃
Introduced in House2025-02-1224.9K⠃⠗⠋
Reported in House2025-10-3134.3K⠃⠗⠋
Engrossed in House—29.0K⠃⠗⠋